Spectrum Pharmaceuticals, Inc.SPPINASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
15.38%
↑ 126% vs avg
Percentile
P64
Within normal range
Streak
1 qtr
Consecutive growthAccelerating
Average
-59.64%
Historical baseline
| Period | Value |
|---|---|
| Q1 2023 | 15.38% |
| Q4 2022 | -41.48% |
| Q3 2022 | 23.62% |
| Q2 2022 | 22.61% |
| Q1 2022 | 0.17% |
| Q4 2021 | -21.40% |
| Q3 2021 | 15.69% |
| Q2 2021 | 14.04% |
| Q1 2021 | -3.57% |
| Q4 2020 | -19.22% |
| Q3 2020 | -3.27% |
| Q2 2020 | 18.88% |
| Q1 2020 | -6.90% |
| Q4 2019 | -15.14% |
| Q3 2019 | 25.36% |
| Q2 2019 | 9.39% |
| Q1 2019 | -225.39% |
| Q4 2018 | -13.50% |
| Q3 2018 | 13.25% |
| Q2 2018 | 53.25% |
| Q1 2018 | -107.36% |
| Q4 2017 | -98.34% |
| Q3 2017 | -1066.27% |
| Q2 2017 | 103.34% |
| Q1 2017 | -498.13% |
| Q4 2016 | 74.02% |
| Q3 2016 | 24.09% |
| Q2 2016 | -140.86% |
| Q1 2016 | -328.41% |
| Q4 2015 | 133.18% |
| Q3 2015 | -151.14% |
| Q2 2015 | 445.66% |
| Q1 2015 | -147.99% |
| Q4 2014 | 13.72% |
| Q3 2014 | -38.14% |
| Q2 2014 | 139.16% |
| Q1 2014 | -604.91% |
| Q4 2013 | 158.88% |
| Q3 2013 | 26.09% |
| Q2 2013 | -184.09% |